Join Prof. Han-Byoel Lee for an insightful commentary on the adverse effects of breast cancer treatment and improving quality of life, with an emphasis on recent developments in the treatment of breast cancer.

Join Dr. Nick Zdenkowski for an insightful commentary on breast cancer therapeutics. He will cover the latest clinical trial results and emerging therapies, including CDK4/6 inhibitors, antibody-drug conjugates (ADCs), endocrine therapy, and PARP inhibitors. Dr. Zdenkowski will discuss the mechanisms of action, efficacy, and safety profiles of these treatments.